All In MedTech

Device Trial Radar · NCT05888194

The Effect of Mucogyne® Gel on Wound Healing

Last checked: Nov 20, 2026Latest source record: Mar 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 118 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

118

Planned (sponsor's estimate)

Start

Jun 12, 2023

Primary completion

May 2024

Study completion May 2024

Sponsor

Lead sponsor
BiocodexNot on our public-company list
Sponsor type
Industry
First posted
Jun 5, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this post-market clinical follow up study is to confirm the efficacy and safety of topical application of Mucogyne® gel in the process of wound healing, when used in accordance with its approved labeling, in the context of postpartum perineal wounds.

Conditions

  • Perineal Tear and Episiotomy

Interventions

  • Mucogyne® gelDevice

    In Mucogyne group, each eligible patient will receive a box of Mucogyne® gel. The patient will apply Mucogyne® gel, 48-hours after delivery, everyday, twice a day, massaging it into the intimate area, for a 10-day period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the effectiveness of topical application of Mucogyne® gel in postpartum perineal wound healing promotion.Time frame: Day 0 to Day 12 (+/-2) after delivery

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Lille

    Lille, France · Recruiting

  • CHU Montpellier

    Montpellier, France · Recruiting

  • CHU Strasbourg

    Strasbourg, France · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.